Michael J. Yang, EVP and CCO at ACADIA PHARMACEUTICALS INC (ACAD), sold 210,958 shares at $44.49 ($9.4M) on 2019-12-12, disclosed to the SEC on 2019-12-13.
Open-market sale of $9.4M ACAD by EVP and CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.73 | 5,032 | $220K | 2.3% |
| 2 | $43.74 | 5,032 | $220K | 2.3% |
| 3 | $44.49 | 100,447 | $4.5M | 47.7% |
| 4 | $44.49 | 100,447 | $4.5M | 47.7% |
| Total | $44.46 avg | 210,958 | $9.4M | 100% |
| Filing → |
| ACAD | SELL | 2020-10-19 | $106K | — | Filing → |
| ACAD | SELL | 2020-07-09 | $2.4M | — | Filing → |
| ACAD | SELL | 2020-05-01 | $148K | — | Filing → |